Comparison of Angiogenic, Cytoprotective, and Immunosuppressive Properties of Human Amnion- and Chorion-Derived Mesenchymal Stem Cells

Although mesenchymal stem cells (MSCs) can be obtained from the fetal membrane (FM), little information is available regarding biological differences in MSCs derived from different layers of the FM or their therapeutic potential. Isolated MSCs from both amnion and chorion layers of FM showed similar morphological appearance, multipotency, and cell-surface antigen expression. Conditioned media obtained from amnion- and chorion-derived MSCs inhibited cell death caused by serum starvation or hypoxia in endothelial cells and cardiomyocytes. Amnion and chorion MSCs secreted significant amounts of angiogenic factors including HGF, IGF-1, VEGF, and bFGF, although differences in the cellular expression profile of these soluble factors were observed. Transplantation of human amnion or chorion MSCs significantly increased blood flow and capillary density in a murine hindlimb ischemia model. In addition, compared to human chorion MSCs, human amnion MSCs markedly reduced T-lymphocyte proliferation with the enhanced secretion of PGE2, and improved the pathological situation of a mouse model of acute graft-versus-host disease. Our results highlight that human amnion- and chorion-derived MSCs, which showed differences in their soluble factor secretion and angiogenic/immuno-suppressive function, could be ideal cell sources for regenerative medicine.

[1]  T. Ikeda,et al.  Transplantation of Allogenic Fetal Membrane-Derived Mesenchymal Stem Cells Protects against Ischemia/Reperfusion-Induced Acute Kidney Injury , 2014, Cell transplantation.

[2]  T. Ikeda,et al.  Allogeneic Transplantation of Fetal Membrane–Derived Mesenchymal Stem Cell Sheets Increases Neovascularization and Improves Cardiac Function after Myocardial Infarction in Rats , 2013, Transplantation.

[3]  O. Parolini,et al.  Characterization of the Conditioned Medium from Amniotic Membrane Cells: Prostaglandins as Key Effectors of Its Immunomodulatory Activity , 2012, PloS one.

[4]  T. Ikeda,et al.  Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis. , 2012, Journal of molecular and cellular cardiology.

[5]  Sung-Whan Kim,et al.  Amniotic Mesenchymal Stem Cells Enhance Wound Healing in Diabetic NOD/SCID Mice through High Angiogenic and Engraftment Capabilities , 2012, PloS one.

[6]  Jung Min Lee,et al.  Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells. , 2012, International immunopharmacology.

[7]  T. Soma,et al.  Human umbilical cord provides a significant source of unexpanded mesenchymal stromal cells. , 2012, Cytotherapy.

[8]  T. Ikeda,et al.  Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. , 2010, Journal of molecular and cellular cardiology.

[9]  T. Ikeda,et al.  Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis. , 2010, American journal of physiology. Renal physiology.

[10]  T. Ikeda,et al.  Allogeneic Injection of Fetal Membrane‐Derived Mesenchymal Stem Cells Induces Therapeutic Angiogenesis in a Rat Model of Hind Limb Ischemia , 2008, Stem cells.

[11]  K. Nakao,et al.  Augmentation of Neovascularizaiton in Hindlimb Ischemia by Combined Transplantation of Human Embryonic Stem Cells-Derived Endothelial and Mural Cells , 2008, PloS one.

[12]  Dar-Yu Yang,et al.  Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell , 2006, Journal of Clinical Neuroscience.

[13]  Hidezo Mori,et al.  Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction , 2006, Nature Medicine.

[14]  W. Holzgreve,et al.  Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. , 2005, American journal of obstetrics and gynecology.

[15]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[16]  J. Ingwall,et al.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.

[17]  M. Pittenger,et al.  Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.

[18]  F. Candotti,et al.  Engraftment Potential of Human Amnion and Chorion Cells Derived from Term Placenta , 2004, Transplantation.

[19]  T. Nikaido,et al.  Human Amnion-Isolated Cells Normalize Blood Glucose in Streptozotocin-Induced Diabetic Mice , 2003, Cell transplantation.

[20]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[21]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[22]  K. Nakao,et al.  Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. , 1995, The Journal of clinical investigation.